Nitroblue tetrazolium dye reduction by peripheral leukocytes from rheumatoid arthritis and systemic lupus erythematosus patients measured by a histochemical and spectrophotometric method.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy; D006651:Histocytochemistry; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D066298:In Vitro Techniques; D007962:Leukocytes / Q000032:analysis / Q000378:metabolism*; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000188:drug therapy; D008722:Methods; D008875:Middle Aged; D009000:Monocytes / Q000378:metabolism; D009504:Neutrophils / Q000378:metabolism; D009574:Nitro Compounds / Q000378:metabolism; D010084:Oxidation-Reduction; D010586:Phagocytes / Q000378:metabolism; D010587:Phagocytosis; D011239:Prednisolone / Q000627:therapeutic use; D013053:Spectrophotometry; D013778:Tetrazolium Salts / Q000378:metabolism*
D009574:Nitro Compounds; D013778:Tetrazolium Salts; D006886:Hydroxychloroquine; D011239:Prednisolone